Hyep Ivan (CIK 2034668) reported 33 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy BCAX (12,500 shares), Sell BCAX (12,500 shares), Buy BCAX (12,500 shares), Sell BCAX (22,757 shares), Sell BCAX (4,413 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 12,500 | $47,372 |
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 12,500 | $349,591 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 12,500 | $47,372 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 22,757 | $650,896 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 4,413 | $131,616 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 830 | $25,160 |
| 2026-05-26 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 9,200 | $34,866 |
| 2026-05-26 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 9,200 | $187,883 |
| 2026-04-22 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 9,200 | $34,866 |
| 2026-04-22 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 9,200 | $211,614 |
| 2026-03-24 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 9,200 | $34,868 |
| 2026-03-24 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 9,200 | $170,384 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 6,237 | $23,638 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 13,555 | $246,972 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 2,963 | $11,230 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 2,963 | $54,075 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 7,318 | $27,735 |
| 2026-01-26 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 1,882 | $7,133 |
| 2026-01-26 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 1,882 | $34,158 |
| 2025-12-23 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 9,200 | $34,868 |
| 2025-12-23 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 9,200 | $168,452 |
| 2025-11-25 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 17,795 | $330,097 |
| 2025-11-25 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 605 | $2,293 |
| 2025-11-25 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Sell | 605 | $10,981 |
| 2025-11-25 | Bicara Therapeutics Inc. (BCAX) | Chief Financial Officer | Buy | 17,795 | $67,443 |
Source: SEC Form 4 filings · as of 2026-08-12